PT Indo Acidatama Tbk (IDX:SRSN)
50.00
0.00 (0.00%)
Apr 30, 2025, 3:12 PM WIB
PT Indo Acidatama Tbk Balance Sheet
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 4,674 | 18,160 | 14,505 | 24,462 | 40,473 | Upgrade
|
Cash & Short-Term Investments | 4,674 | 18,160 | 14,505 | 24,462 | 40,473 | Upgrade
|
Cash Growth | -74.26% | 25.20% | -40.70% | -39.56% | 47.79% | Upgrade
|
Accounts Receivable | 206,539 | 184,271 | 181,007 | 122,670 | 181,456 | Upgrade
|
Other Receivables | 1,948 | 574.7 | 1,009 | 149.24 | 62.91 | Upgrade
|
Receivables | 208,487 | 184,845 | 182,016 | 122,819 | 181,519 | Upgrade
|
Inventory | 491,432 | 380,841 | 332,032 | 369,058 | 348,396 | Upgrade
|
Prepaid Expenses | 1,157 | 1,306 | 1,007 | 679.45 | 1,701 | Upgrade
|
Other Current Assets | 31,500 | 7,398 | 8,730 | 11,369 | 7,305 | Upgrade
|
Total Current Assets | 737,249 | 592,551 | 538,290 | 528,388 | 579,394 | Upgrade
|
Property, Plant & Equipment | 396,982 | 341,230 | 334,577 | 324,352 | 319,820 | Upgrade
|
Long-Term Deferred Tax Assets | - | 1,959 | 2,778 | 6,657 | 6,867 | Upgrade
|
Other Long-Term Assets | 1,198 | 958 | 958 | 766 | 766 | Upgrade
|
Total Assets | 1,135,429 | 936,698 | 876,602 | 860,163 | 906,847 | Upgrade
|
Accounts Payable | 28,272 | 26,199 | 20,852 | 30,249 | 15,848 | Upgrade
|
Accrued Expenses | 16,627 | 14,360 | 9,794 | 6,178 | 11,095 | Upgrade
|
Short-Term Debt | 306,301 | 147,010 | 147,964 | 165,741 | 223,071 | Upgrade
|
Current Portion of Long-Term Debt | 2,500 | 6,866 | 8,114 | 8,114 | 8,114 | Upgrade
|
Current Portion of Leases | 2,604 | 919.27 | 646.84 | 1,316 | 2,956 | Upgrade
|
Current Income Taxes Payable | 601.66 | 4,327 | 3,554 | 1,210 | 5,361 | Upgrade
|
Current Unearned Revenue | 20,186 | 5,667 | - | - | - | Upgrade
|
Other Current Liabilities | 16.15 | 13.39 | 264.07 | 210.75 | 392.41 | Upgrade
|
Total Current Liabilities | 377,108 | 205,361 | 191,189 | 213,017 | 266,837 | Upgrade
|
Long-Term Debt | - | 2,500 | 9,366 | 17,480 | 25,594 | Upgrade
|
Long-Term Leases | 3,373 | 976.45 | 657.72 | 372.82 | 1,574 | Upgrade
|
Long-Term Deferred Tax Liabilities | 911.41 | - | - | - | - | Upgrade
|
Total Liabilities | 396,872 | 226,110 | 218,260 | 251,955 | 318,959 | Upgrade
|
Common Stock | 301,000 | 301,000 | 301,000 | 301,000 | 301,000 | Upgrade
|
Additional Paid-In Capital | 600 | 600 | 600 | 600 | 600 | Upgrade
|
Retained Earnings | 271,766 | 255,284 | 203,286 | 169,646 | 149,123 | Upgrade
|
Comprehensive Income & Other | 165,191 | 153,703 | 153,456 | 136,961 | 137,164 | Upgrade
|
Shareholders' Equity | 738,557 | 710,588 | 658,342 | 608,207 | 587,887 | Upgrade
|
Total Liabilities & Equity | 1,135,429 | 936,698 | 876,602 | 860,163 | 906,847 | Upgrade
|
Total Debt | 314,779 | 158,271 | 166,748 | 193,023 | 261,309 | Upgrade
|
Net Cash (Debt) | -310,105 | -140,111 | -152,243 | -168,561 | -220,836 | Upgrade
|
Net Cash Per Share | -51.51 | -23.27 | -25.29 | -28.00 | -36.68 | Upgrade
|
Filing Date Shares Outstanding | 6,020 | 6,020 | 6,020 | 6,020 | 6,020 | Upgrade
|
Total Common Shares Outstanding | 6,020 | 6,020 | 6,020 | 6,020 | 6,020 | Upgrade
|
Working Capital | 360,142 | 387,190 | 347,101 | 315,370 | 312,557 | Upgrade
|
Book Value Per Share | 122.68 | 118.04 | 109.36 | 101.03 | 97.66 | Upgrade
|
Tangible Book Value | 738,557 | 710,588 | 658,342 | 608,207 | 587,887 | Upgrade
|
Tangible Book Value Per Share | 122.68 | 118.04 | 109.36 | 101.03 | 97.66 | Upgrade
|
Land | 196,825 | 184,320 | 182,061 | 173,223 | 173,046 | Upgrade
|
Buildings | 56,546 | 48,620 | 47,294 | 35,238 | 32,993 | Upgrade
|
Machinery | 455,613 | 415,042 | 397,350 | 384,613 | 341,342 | Upgrade
|
Construction In Progress | 3,160 | 986.7 | 411.9 | 2,034 | 29,059 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.